Header Logo

Connection

GEORGE NOON to Heart Transplantation

Back to Details
This is a "connection" page, showing publications GEORGE NOON has written about Heart Transplantation.
GEORGE NOON
Connection Strength
1.531
Heart Transplantation
  1. Heterotopic heart transplantation: the United States experience. Heart Surg Forum. 2014 Jun; 17(3):E132-40.
    View in: PubMed
    Score: 0.279
  2. Safety and feasibility trial of the MicroMed DeBakey ventricular assist device as a bridge to transplantation. J Am Coll Cardiol. 2005 Mar 15; 45(6):962-3.
    View in: PubMed
    Score: 0.147
  3. Patient selection for assist devices: bridge to transplant. Curr Opin Cardiol. 2003 Mar; 18(2):141-6.
    View in: PubMed
    Score: 0.128
  4. End-stage cardiac failure in a morbidly obese patient treated by biliopancreatic diversion and cardiac transplantation. Obes Surg. 2002 Jun; 12(3):416-8.
    View in: PubMed
    Score: 0.121
  5. Use of a donor heart that had undergone previous cardiac surgery for ASD closure. J Heart Lung Transplant. 2002 Feb; 21(2):294-5.
    View in: PubMed
    Score: 0.119
  6. [Heterotopic heart transplantation: 13-year experience at the Methodist Hospital of the Baylor Medical College]. Arch Inst Cardiol Mex. 1999 Nov-Dec; 69(6):526-33.
    View in: PubMed
    Score: 0.101
  7. Biliary surgery after cardiac transplantation. Arch Surg. 1991 May; 126(5):571-3.
    View in: PubMed
    Score: 0.056
  8. Current status of the MicroMed DeBakey Noon Ventricular Assist Device. Tex Heart Inst J. 2010; 37(6):652-3.
    View in: PubMed
    Score: 0.051
  9. Impact of left ventricular assist device (LVAD)-mediated humoral sensitization on post-transplant outcomes. J Heart Lung Transplant. 2005 Dec; 24(12):2054-9.
    View in: PubMed
    Score: 0.038
  10. Simvastatin decreases myocardial tumor necrosis factor alpha content in heart transplant recipients. J Heart Lung Transplant. 2005 Jan; 24(1):46-51.
    View in: PubMed
    Score: 0.036
  11. Cardiac hypertrophy after transplantation is associated with persistent expression of tumor necrosis factor-alpha. Circulation. 2001 Aug 07; 104(6):676-81.
    View in: PubMed
    Score: 0.029
  12. Development and clinical application of the MicroMed DeBakey VAD. Curr Opin Cardiol. 2000 May; 15(3):166-71.
    View in: PubMed
    Score: 0.026
  13. Cardiac transplantation: the final therapeutic option for the treatment of heart failure. Curr Opin Cardiol. 2000 May; 15(3):178-82.
    View in: PubMed
    Score: 0.026
  14. [The DeBakey VAD axial flow pump: first clinical experience with a new generation of implantable, nonpulsatile blood pumps for long-term support prior to transplantation]. Wien Klin Wochenschr. 1999 Sep 03; 111(16):629-35.
    View in: PubMed
    Score: 0.025
  15. Heterotopic heart transplantation: catheterization, endomyocardial biopsy, and coronary angiography of the donor heart. Cathet Cardiovasc Diagn. 1994 May; 32(1):18-26.
    View in: PubMed
    Score: 0.017
  16. Anatomic constraints for a total artificial heart in orthotopic heart transplant recipients. J Heart Lung Transplant. 1994 Mar-Apr; 13(2):250-62.
    View in: PubMed
    Score: 0.017
  17. Case 3--1993. Combined abdominal aortic aneurysm resection and cholecystectomy following prior heart transplantation. J Cardiothorac Vasc Anesth. 1993 Oct; 7(5):610-4.
    View in: PubMed
    Score: 0.017
  18. Degree of HLA mismatch as a predictor of death from allograft arteriopathy after heart transplant. Transplant Proc. 1993 Feb; 25(1 Pt 1):233-6.
    View in: PubMed
    Score: 0.016
  19. Circulatory support 1991. The Second International Conference on Circulatory Support Devices for Severe Cardiac Failure. Management of secondary organ dysfunction. Ann Thorac Surg. 1993 Jan; 55(1):222-6.
    View in: PubMed
    Score: 0.016
  20. Attenuation of waiting time mortality with heterotopic heart transplantation. Ann Thorac Surg. 1992 Sep; 54(3):547-51.
    View in: PubMed
    Score: 0.015
  21. Detection of asymptomatic myocardial ischemia in a heart transplant patient before sudden death. J Heart Lung Transplant. 1991 Nov-Dec; 10(6):1026-8.
    View in: PubMed
    Score: 0.015
  22. Sudden death caused by bradycardia and asystole in a heart transplant patient with coronary arteriopathy. J Heart Lung Transplant. 1991 Nov-Dec; 10(6):931-6.
    View in: PubMed
    Score: 0.015
  23. Anatomic fit study for development of a one piece total artificial heart. ASAIO Trans. 1991 Jul-Sep; 37(3):M254-5.
    View in: PubMed
    Score: 0.014
  24. Dynamics of soluble interleukin-2 receptor levels immediately after heart transplantation. Attenuation of increase by OKT3 therapy. Transplantation. 1991 Jul; 52(1):78-82.
    View in: PubMed
    Score: 0.014
  25. Heterotopic heart transplantation and native heart ventricular arrhythmias. Ann Thorac Surg. 1991 Jun; 51(6):987-91.
    View in: PubMed
    Score: 0.014
  26. Inability of isolated soluble interleukin-2 receptor levels to predict biopsy rejection scores after heart transplantation. Transplantation. 1991 Mar; 51(3):636-41.
    View in: PubMed
    Score: 0.014
  27. Insensitivity of noninvasive tests to detect coronary artery vasculopathy after heart transplant. Am J Cardiol. 1991 Feb 01; 67(4):243-7.
    View in: PubMed
    Score: 0.014
  28. Pulmonary function after heart-lung transplantation using larger donor organs. Am Rev Respir Dis. 1990 Nov; 142(5):1026-9.
    View in: PubMed
    Score: 0.014
  29. The older cardiac transplant donor. Relation to graft function and recipient survival longer than 6 years. Circulation. 1989 Nov; 80(5 Pt 2):III126-32.
    View in: PubMed
    Score: 0.013
  30. Dynamic changes in soluble interleukin-2 receptor levels after lung or heart-lung transplantation. Am Rev Respir Dis. 1989 Sep; 140(3):789-96.
    View in: PubMed
    Score: 0.013
  31. Implantable electrical left ventricular assist system: bridge to transplantation and the future. Ann Thorac Surg. 1989 Jan; 47(1):142-50.
    View in: PubMed
    Score: 0.012
  32. Heart transplantation: no longer an experiment. Tex Med. 1988 Dec; 84(12):48-55.
    View in: PubMed
    Score: 0.012
  33. Increased expression of stem cell factor and its receptor after left ventricular assist device support: a potential novel target for therapeutic interventions in heart failure. J Heart Lung Transplant. 2008 Jul; 27(7):701-9.
    View in: PubMed
    Score: 0.011
  34. Systolic and diastolic ventricular performance at rest and during exercise in heart transplant recipients. J Heart Transplant. 1988 Mar-Apr; 7(2):145-51.
    View in: PubMed
    Score: 0.011
  35. Hyperlipidemia following heart transplantation: natural history and intervention with mevinolin (lovastatin). Transplant Proc. 1987 Aug; 19(4 Suppl 5):60-2.
    View in: PubMed
    Score: 0.011
  36. Evolution of hemodynamics after orthotopic heart and heart-lung transplantation: early restrictive patterns persisting in occult fashion. J Heart Transplant. 1987 Jan-Feb; 6(1):34-43.
    View in: PubMed
    Score: 0.010
  37. Early mobilization of LVAD recipients who require prolonged mechanical ventilation. Tex Heart Inst J. 2006; 33(2):130-3.
    View in: PubMed
    Score: 0.010
  38. Rupture of inlet graft of the HeartMate System: a case report. J Heart Lung Transplant. 2006 Jan; 25(1):137-9.
    View in: PubMed
    Score: 0.010
  39. First Turkish experience with the MicroMed DeBakey VAD. Tex Heart Inst J. 2003; 30(2):114-20.
    View in: PubMed
    Score: 0.008
  40. First clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation. Circulation. 2000 Feb 01; 101(4):356-9.
    View in: PubMed
    Score: 0.006
  41. Versatile one-piece total artificial heart for bridge to transplantation or permanent heart replacement. Artif Organs. 1992 Dec; 16(6):607-13.
    View in: PubMed
    Score: 0.004
  42. Human cardiac transplantation: clinical experience. J Thorac Cardiovasc Surg. 1969 Sep; 58(3):303-17.
    View in: PubMed
    Score: 0.003
  43. Lung transplantation: an emerging technology. Tex Med. 1988 Dec; 84(12):61-7.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.